DarioHealth Corp. Files 8-K: Leadership and Compensation Changes
Ticker: DRIO · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, compensation, board-of-directors
TL;DR
DarioHealth board shakeup and comp changes filed. Watch closely.
AI Summary
On July 10, 2025, DarioHealth Corp. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates a shift in leadership and potential adjustments to how key personnel are compensated.
Why It Matters
Changes in board composition and executive compensation can signal strategic shifts or financial adjustments within the company, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty about the company's future direction and financial stability.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- July 10, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 322 W. 57th St , #33B New York , New York 10019 (address) — Principal Executive Offices
- LabStyle Innovations Corp. (company) — Former Company Name
FAQ
What specific changes were made to the board of directors?
The filing indicates changes related to the 'Departure of Directors or Certain Officers' and 'Election of Directors', but the specific names and details of these changes are not provided in the excerpt.
What are the details of the executive compensation arrangements mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of these arrangements are not included in the provided text.
When was DarioHealth Corp. incorporated?
DarioHealth Corp. was incorporated in Delaware.
What was the former name of DarioHealth Corp.?
The former name of DarioHealth Corp. was LabStyle Innovations Corp., with a name change date of November 1, 2011.
What is the principal business address of DarioHealth Corp.?
The principal executive offices are located at 322 W. 57th St , #33B New York , New York 10019.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding DarioHealth Corp. (DRIO).